Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design.
第一作者:
Nicole,Mayer-Hamblett
第一单位:
Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, Washington.;Department of Pediatrics and.;Department of Biostatistics, University of Washington, Seattle, Washington.
作者:
医学主题词
氨基酚类(Aminophenols);苯并二恶茂类(Benzodioxoles);囊性纤维化(Cystic Fibrosis);囊性纤维化跨膜传导调节因子(Cystic Fibrosis Transmembrane Conductance Regulator);人类(Humans);喹诺酮类(Quinolones)
DOI
10.1513/AnnalsATS.202010-1336SD
PMID
33465316
发布时间
2024-08-17
基金项目
UL1 TR002548/TR/NCATS NIH HHS/United States
P30 DK089507/DK/NIDDK NIH HHS/United States
P30 DK117469/DK/NIDDK NIH HHS/United States
UL1 TR002319/TR/NCATS NIH HHS/United States
R01 HL124053/HL/NHLBI NIH HHS/United States
P01 HL128192/HL/NHLBI NIH HHS/United States
- 浏览1
Annals of the American Thoracic Society
2021年18卷8期
1397-1405页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



